New clues to pancreas and diabetes
Findings suggest that macrophages are key players in the development of pancreatic endocrine cells
Scientists create “cloaked” donor cell and tissue grafts that escape rejection by the immune system
New research could transform cell therapies for incurable diseases
New Medicine by Design-funded research advances an under-skin cell therapy for type 1 diabetes
Research shows that transplanted pancreatic cells were able to survive in animal hosts.
Enabling long-lasting cell therapy for diabetes without injection
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Cloaking cells to evade the immune system
Can turning off genetic switches in therapeutic cells help them avoid attack from the immune system?
Medicine by Design-funded research finds transplanting insulin-producing cells with blood vessels may help reverse diabetes
Researchers have engineered a new method to improve the survival and potency of cell transplants to treat diabetes.
Medicine by Design’s executive director launches new chapter in diabetes research with JDRF grant
$430,000 investment to study if a type of immune cell could be the key to transplanting insulin-producing cells for diabetes treatment
Medicine by Design and OIRM invest $1.2 million in technologies and research to advance innovation in regenerative medicine
Twelve targeted projects and two post-doctoral fellowships that are expanding the frontiers of stem cell research will share $1.2 million in funding thanks to programs supported jointly by the University of Toronto’s Medicine by Design initiative and the Ontario Institute for Regenerative Medicine.